Selected EAE-Related Publications
Neurol. Sci. 56 147-153Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis.
Med. Inflamm.Glutamate receptors in neuroinflammatory demyelinating disease.
Int. Arch. Allergy Immunol. 114 74-80.Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids.
Eur. J. Pharmacol. 601 88-93.The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrination (III) chloride, (FeTPPS).
Fund. Clin. Pharmacol.The N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801, influences prostaglandin levels in specific areas of the central nervous system during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).